Latent, a clinical-AI company focused on accelerating access to life-saving medications, has secured $80 million in Series A funding. The round was co-led by Spark Capital and Transformation Capital, with participation from McKesson Ventures and General Catalyst, among others. Latent's technology aims to bridge the gap between advanced medicine and its delivery systems within healthcare.